Ethanol Extract of Huang-Jin-Shuang-Shen Enhances Oxaliplatin Responses in Gastric Cancer Models: Associations with FBLN1 and Mitochondrial Dysfunction
Pharmaceuticals · 08.11.2026 · 19 (11) · 1771
DOI: 10.3390/ph19111771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 08.11.2026. Verfasst von Linfeng Zheng und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Zhejiang Traditional Chinese Medical Science and Technology Program, the Zhejiang Provincial Leading Project for Leading Geese Plan.
Abstract (Originalsprache)
Background
Platinum-based chemotherapy, particularly oxaliplatin (OXA), is a primary treatment modality for advanced gastric carcinoma. However, the development of apoptotic resistance and enhanced DNA repair mechanisms frequently compromises its enduring clinical benefit.
Objectives
The present research aims to evaluate whether an ethanol extract of Huang-Jin-Shuang-Shen (HJSS-E) can modulate cellular sensitivity to oxaliplatin and to characterize the associated molecular pathways.
Methods
Potential interacting proteins were screened through an integration of DARTS-based proteomics and transcriptomic database mining (TCGA). The subsequent biological effects were examined employing RNA sequencing, fluorescent organelle probes (Rhod-2 AM and JC-1), murine tumor models, patient-derived organoids (PDOs), and multiplex immunofluorescence (mIF) at single-cell resolution.
Results
HJSS-E enhanced OXA-associated DNA damage and apoptosis in gastric cancer cells and improved treatment responses in xenograft and patient-derived organoid models. Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA) identified Fibulin-1 (FBLN1) as a candidate target. Combination treatment was associated with altered Ryanodine Receptor 2 (RYR2)/Sirtuin 3 (SIRT3) expression, reduced ATP content and NAD+/NADH ratios, and increased mitochondria-associated Rhod-2 fluorescence. Salvianolic acid A (SAA) interacted with recombinant FBLN1 in SPR assays and reproduced selected cellular effects of HJSS-E.
Conclusions
HJSS-E potentiates the antitumor efficacy of OXA in preclinical gastric cancer models, accompanied by mitochondrial dysfunction and coordinated alterations in RYR2/SIRT3 expression. FBLN1 emerges as a candidate molecular mediator of this response.
Förderung
- National Natural Science Foundation of China
- the Zhejiang Traditional Chinese Medical Science and Technology Program
- the Zhejiang Provincial Leading Project for Leading Geese Plan
- the Zhejiang Medical and Health Science and Technology Program
Zitieren
APA
Zheng, L., Du, J., Ni, X., Wang, C., Zhang, K., Fan, W., Guo, J., Zhang, M., Zhu, X., Jiang, T., & Zhang, G. (2026). Ethanol Extract of Huang-Jin-Shuang-Shen Enhances Oxaliplatin Responses in Gastric Cancer Models: Associations with FBLN1 and Mitochondrial Dysfunction. Pharmaceuticals, 19(11), 1771. https://doi.org/10.3390/ph19111771
Vancouver
Zheng L, Du J, Ni X, Wang C, Zhang K, Fan W, et al. Ethanol Extract of Huang-Jin-Shuang-Shen Enhances Oxaliplatin Responses in Gastric Cancer Models: Associations with FBLN1 and Mitochondrial Dysfunction. Pharmaceuticals. 2026;19(11):1771. doi:10.3390/ph19111771
BibTeX
@article{Zheng2026,
author = {Zheng, Linfeng and Du, Jiazhe and Ni, Xiaochen and Wang, Chuhang and Zhang, Kaiyuan and Fan, Wei and Guo, Jianing and Zhang, Mingsi and Zhu, Xiu and Jiang, Tao and Zhang, Guangji},
title = {Ethanol Extract of Huang-Jin-Shuang-Shen Enhances Oxaliplatin Responses in Gastric Cancer Models: Associations with FBLN1 and Mitochondrial Dysfunction},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {11},
pages = {1771},
doi = {10.3390/ph19111771}
}
EUVIMED